Cubist Pharmaceuticals

Cubist in the News

Press Briefing—The MRSA Threat

MRSA Backgrounder (pdf)

MRSA By the Numbers (pdf)

MRSA Expert Quotes (pdf)

The Changing Face of MRSA Heightens Concern Over Public Health Crisis (pdf)

Mike Bonney

Barry Eisenstein, M.D.

Barry Eisenstein, M.D. article in Infectious Disease Special Edition-September 2009,
October 21, 2009

Dr. Barry Eisenstein's Op Ed is featured in The Boston Globe, October 19, 2009

Mike Bonney appeared on New England Cable News' (NECN) "This Week in Business", June 21, 2009

Barry Eisenstein, M.D., featured in Life Science Leader, March 2009

Drug Maker Targets Infections That Are Resistant to Antibiotics, Investor's Business Daily, November 2008

Cubist's Barry Eisenstein, M.D., Testifies on Need to Encourage Antibiotic Research & Development: Antimicrobial Resistance Reaching "Crisis Point"

Mike Bonney and Jared Silverman were interviewed at Cubist by New England Cable News (NECN), April 2008

Cubist's Barry Eisenstein, M.D. and Steven Gilman, Ph.D. are quoted in Chemical & Engineering News, April 14th, 2008 Cover story (posted with permission)

Barry Eisenstein, M.D.'s article recently published In Expert Opinion on Drug Discovery: Use of daptomycin for treatment of Staphylococcus aureus infections

Cubist's Barry Eisenstein, M.D. quoted in PharmaVOICE "Super Bugs" Article by Cynthia Borda, PharmaVoice, February 2008 (PDF)

See also archive of earlier Cubist in the News material.

Site Map Terms of Use and Privacy Policy

Contact Us - 65 Hayden Avenue, Lexington, MA 02421 p.781.860.8660 f.781.240.0256